title: Oral lichenoid eruption associated with imatinib treatment.
authors.forename: Cristina
authors.initials: C
authors.lastname: Gómez Fernández
authors.forename: Elena
authors.initials: E
authors.lastname: Sendagorta Cudós
authors.forename: Beatriz
authors.initials: B
authors.lastname: Casado Verrier
authors.forename: Marta
authors.initials: M
authors.lastname: Feito Rodríguez
authors.forename: Judith
authors.initials: J
authors.lastname: Suárez Aguado
authors.forename: Carmen
authors.initials: C
authors.lastname: Vidaurrázaga Díaz de Arcaya
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D017512:Lichenoid Eruptions / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D009059:Mouth Diseases / Q000139:chemically induced* / Q000473:pathology; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate